Exchange: NYSEArca·Updated 07:30 PM EST

PSIL News

News
all
press releases
HELP Stock Slides As Suicide Attempt Overshadows Strong Late-stage Depression Trial Data
The company said that there were three treatment-related serious adverse events reported with HLP003 in a late-stage trial, though it met its main goal.
Stocktwits
HELP Stock Slides As Suicide Attempt Overshadows Strong Late-stage Depression Trial Data
The company said that there were three treatment-related serious adverse events reported with HLP003 in a late-stage trial, though it met its main goal.
Stocktwits
More News
Barclays’ new price target of $35 implies an upside of about 150% from the stock’s last close on Thursday around $14.
Stocktwits
TD Cowen lifted its target on HELP to $62 from $8 on Thursday, while maintaining a Buy rating.
Stocktwits
Wells Fargo began coverage on five biotech stocks on Monday, with only Compass Pathways receiving an ‘Equal-Weight’ rating while the rest received ‘Overweight’ ratings.
Stocktwits
Helus Pharma said it completed enrollment ahead of schedule in the Phase 3 study evaluating HLP003 as an adjunctive treatment for major depressive disorder.
Stocktwits
H.C. Wainwright and Berenberg became the latest firms to downgrade the stock following Eli Lilly's acquisition agreement.
Stocktwits
Both ATAI and CMPS stocks were among the top trending on Stocktwits in pre-market trade.
Stocktwits
The FDA stated that this will increase support for psychedelic-based medicines for the treatment of conditions like post-traumatic stress disorder, treatment-resistant depression, and major depressive disorder.
Stocktwits
AdvisorShares Applauds Executive Order Accelerating Access to Psychedelic Therapies AdvisorShares Applauds Executive Order Accelerating Access to Psychedelic Therapies PR Newswire BETHESDA, Md...
PR Newswire
Enveric stated during after-market hours on Thursday that it has entered into definitive agreements for the purchase and sale of 2.2 million shares of its common stock at a purchase price of $2.25.
Stocktwits

Advertisement|Remove ads.